Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis	HEPATOLOGY COMMUNICATIONS	2020
Features of severe COVID-19. a systematic review and meta-analysis	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2020
Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in patients with COVID-19	CLINICAL AND TRANSLATIONAL SCIENCE	2020
Clinical and pharmacological characteristics of elderly patients admitted for bleeding. iimpact on in-hospital mortality	ANNALS OF MEDICINE	2020
Effects of atrial fibrillation and chronic kidney disease on major adverse cardiovascular events	THE AMERICAN JOURNAL OF CARDIOLOGY	2020
Antiphospholipid antibodies in end-stage renal disease. a systematic review and meta-analysis	HEMODIALYSIS INTERNATIONAL	2020
Increased liver localization of lipopolysaccharides in human and experimental NAFLD	HEPATOLOGY	2020
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress	NUTRIENTS	2020
Family history of atrial fibrillation and risk of cardiovascular events. a multicenter prospective cohort study	CIRCULATION. ARRHYTHMIA AND ELECTROPHYSIOLOGY	2020
T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort	INTERNATIONAL JOURNAL OF CARDIOLOGY	2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2020
Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld)	BIOMEDICINES	2020
Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register	CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS	2020
Anticoagulation in patients with advanced liver disease: an open issue	INTERNAL AND EMERGENCY MEDICINE	2020
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE	2020
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry	INTERNATIONAL JOURNAL OF CARDIOLOGY	2020
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention	THE AMERICAN JOURNAL OF CARDIOLOGY	2020
Antiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis	SEMINARS IN ARTHRITIS AND RHEUMATISM	2020
Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19	CIRCULATION RESEARCH	2020
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease	CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY	2020

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.